Maxigesic producer AFT Pharmaceuticals has returned to positive operating earnings posting a $6.1 million operating profit, compared with a $10.1m loss last year.
The company achieved the turnaround through a reduction in costs. Additional savings are expected as the company is able to secure
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
